54 related articles for article (PubMed ID: 30109954)
1. Hepatocellular Carcinoma: In Vivo Evaluation of Water Percentage as a Prognostic Biomarker Using Magnetic Resonance Imaging 3D-VIBE Multiecho Dixon.
Wang M; Yuan F; Wei Y; Xia C; Hu F; Song B
Cancer Biother Radiopharm; 2018 Sep; 33(7):300-306. PubMed ID: 30109954
[TBL] [Abstract][Full Text] [Related]
2. Mean ADC values and arterial phase hyperintensity discriminate small (≤ 3 cm) well-differentiated hepatocellular carcinoma from dysplastic nodule.
Zong X; Li M; Li J; Chen Q; Shi A; Gao X; Guo R
Abdom Radiol (NY); 2024 Apr; 49(4):1132-1143. PubMed ID: 38289351
[TBL] [Abstract][Full Text] [Related]
3. Dynamic Contrast Enhanced-MRI and Apparent Diffusion Coefficient Quantitation for Differentiate Hepatocellular Carcinoma from Hepatocellular Adenoma.
Alareer HSN; Jasim Taher H; Dinar Abdullah A
Asian Pac J Cancer Prev; 2024 Mar; 25(3):931-937. PubMed ID: 38546075
[TBL] [Abstract][Full Text] [Related]
4. The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis.
Tam HH; Collins DJ; Brown G; Chau I; Cunningham D; Leach MO; Koh DM
Br J Radiol; 2013 Oct; 86(1030):20130281. PubMed ID: 23995873
[TBL] [Abstract][Full Text] [Related]
5. Perfusion of hepatocellular carcinomas measured by diffusion-derived vessel density biomarker: Higher hepatocellular carcinoma perfusion than earlier intravoxel incoherent motion reports.
Li XM; Yao DQ; Quan XY; Li M; Chen W; Wáng YXJ
NMR Biomed; 2024 Jun; 37(6):e5125. PubMed ID: 38361334
[TBL] [Abstract][Full Text] [Related]
6. The Value of CT Perfusion Parameters and Apparent Diffusion Coefficient Value of Magnetic Resonance Diffusion Weighted Imaging in Diagnosis of Hepatocellular Carcinoma.
Li K; Wang B
Comput Math Methods Med; 2022; 2022():2771869. PubMed ID: 36203535
[TBL] [Abstract][Full Text] [Related]
7. Is intravoxel incoherent motion magnetic resonance imaging useful for predicting hepatocellular cancer recurrence and invasion of the peritumoral zone after transarterial chemoembolization?
Zhao X; Wen Q; Wang J; Dou W; Zhang G; Shi H
J Cancer Res Ther; 2024 Apr; 20(2):584-591. PubMed ID: 38687928
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MRI (DWI) for assessment of response to high-dose-rate CT-guided brachytherapy (HDR-BT) of hepatocellular carcinoma.
Karim H; Thormann M; Omari J; Surov A; Schinner R; Seidensticker R; Ingenerf M; Ricke J; Schmid-Tannwald C
Acta Radiol; 2024 Jan; 65(1):14-22. PubMed ID: 36843430
[TBL] [Abstract][Full Text] [Related]
9. Application of synthetic magnetic resonance imaging and DWI for evaluation of prognostic factors in cervical carcinoma: a prospective preliminary study.
Zhang W; Lu N; He H; Liu H; Zhu F; Ma L; Luo Y; Qian L; Meng T; Xie C
Br J Radiol; 2023 Jan; 96(1141):20220596. PubMed ID: 36341699
[TBL] [Abstract][Full Text] [Related]
10. Apparent diffusion coefficient and its standard deviation from diffusion-weighted imaging in preoperative predicting liver invasion by T3-staged resectable gallbladder carcinoma.
Tang Z; Wu YP; Tan BG; Chen XQ; Guo WW; Wu KS; Zhang XM; Chen TW; Zhou HY
Clin Radiol; 2024 Feb; 79(2):e247-e255. PubMed ID: 38007337
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker.
Winfield JM; Wakefield JC; Dolling D; Hall M; Freeman S; Brenton JD; Lutchman-Singh K; Pace E; Priest AN; Quest RA; Taylor NJ; Gabra H; McKnight L; Collins DJ; Banerjee S; Hall E; deSouza NM
Radiology; 2019 Nov; 293(2):374-383. PubMed ID: 31573402
[TBL] [Abstract][Full Text] [Related]
12. Is Apparent Diffusion Coefficient Established as an Imaging Biomarker for Stereotactic Body Radiation Therapy Assessment in Hepatocellular Carcinoma?
Cao Y; Cuneo KC; Evans J; Ten Haken RK; Chang DT; Lawrence TS
Cancer J; 2023 Jul-Aug 01; 29(4):238-242. PubMed ID: 37471615
[TBL] [Abstract][Full Text] [Related]
13. The Apparent Diffusion Coefficient of the Paraspinal and Psoas Muscles Are of Prognostic Relevance in Patients With Hepatocellular Carcinoma Undergoing Transarterial Radioembolization.
Ehrengut C; Schindler A; Seehofer D; Ebel S; Steinhoff K; Sabri O; Berg T; Denecke T; Bömmel FV; Meyer HJ
Cancer Diagn Progn; 2024; 4(3):281-287. PubMed ID: 38707727
[TBL] [Abstract][Full Text] [Related]
14. Associations between apparent diffusion coefficient and electromyography parameters in myositis-A preliminary study.
Meyer HJ; Emmer A; Kornhuber M; Surov A
Brain Behav; 2018 May; 8(5):e00958. PubMed ID: 29761011
[TBL] [Abstract][Full Text] [Related]
15. Prospective validation of diffusion-weighted MRI as a biomarker of tumor response and oncologic outcomes in head and neck cancer: Results from an observational biomarker pre-qualification study.
; Mohamed ASR; Abusaif A; He R; Wahid KA; Salama V; Youssef S; McDonald BA; Naser M; Ding Y; Salzillo TC; AboBakr MA; Wang J; Lai SY; Fuller CD
Radiother Oncol; 2023 Jun; 183():109641. PubMed ID: 36990394
[TBL] [Abstract][Full Text] [Related]
16. Predicting tumor recurrence on baseline MR imaging in patients with early-stage hepatocellular carcinoma using deep machine learning.
Kucukkaya AS; Zeevi T; Chai NX; Raju R; Haider SP; Elbanan M; Petukhova-Greenstein A; Lin M; Onofrey J; Nowak M; Cooper K; Thomas E; Santana J; Gebauer B; Mulligan D; Staib L; Batra R; Chapiro J
Sci Rep; 2023 May; 13(1):7579. PubMed ID: 37165035
[TBL] [Abstract][Full Text] [Related]
17. Apparent diffusion coefficient and tissue stiffness are associated with different tumor microenvironment features of hepatocellular carcinoma.
Chen J; Wu Z; Zhang Z; Chen Y; Yin M; Ehman RL; Yuan Y; Song B
Eur Radiol; 2024 May; ():. PubMed ID: 38767658
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of Diffusion-Weighted Imaging in Evaluating Acute Cellular Rejection and Monitoring Treatment Response in Liver Transplant Recipients.
Chiang HJ; Chuang YH; Li CW; Lin CC; Eng HL; Chen CL; Cheng YF; Chou MC
Diagnostics (Basel); 2024 Apr; 14(8):. PubMed ID: 38667453
[TBL] [Abstract][Full Text] [Related]
19. Liver parenchymal changes detected by MR elastography and diffusion-weighted imaging after stereotactic body radiotherapy for hepatocellular carcinoma.
Omiya Y; Morisaka H; Matsuda M; Saito M; Hashimoto T; Motosugi U; Onishi H
Abdom Radiol (NY); 2023 Nov; 48(11):3353-3361. PubMed ID: 37542553
[TBL] [Abstract][Full Text] [Related]
20. Does Diffusion Magnetic Resonance Imaging (DWI) has Role in Irradiated Laryngeal Carcinoma?
Roushdy MMM; Elsherif MMR; Kayed EMS; Farghaly S; Sayed AR
Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):6339-6346. PubMed ID: 36742495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
